Literature DB >> 8933802

Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings.

H J Lee1, J G Im, J M Ahn, K M Yeon.   

Abstract

PURPOSE: The frequency of lung cancer in patients with idiopathic pulmonary fibrosis (IPF) is higher than that of general population. To evaluate CT findings of lung cancer associated with IPF, we analyzed 32 patients with lung cancer associated with IPF.
METHOD: We analyzed retrospectively 32 patients with histologically confirmed lung cancer out of 244 consecutive cases diagnosed as IPF by either CT and clinical findings (n = 220) or histologically (n = 24). The patients were 40-85 years old (mean 66 years, M/F = 31/1). Scanning techniques were conventional CT in 24 patients, high-resolution CT (HRCT) in 2 patients, and both conventional CT and HRCT in 6 patients. We analyzed the CT patterns, locations, and histologic types of lung cancer.
RESULTS: The frequency of lung cancer in patients with IPF was 13.1% (32/244). In 17 of 32 patients, the CT findings of lung cancer were ill defined lesions mimicking air-space consolidation. Lung cancer was located mainly in the lower lobes (21/32) and peripheral portion (21/32). Histologically, squamous cell carcinoma was the most common type (18/32).
CONCLUSION: Typical CT findings of lung cancer were ill defined consolidation-like masses at the peripheral portion where the most advanced fibrosis was located.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933802     DOI: 10.1097/00004728-199611000-00020

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  13 in total

Review 1.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

2.  Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.

Authors:  K A Khan; M P Kennedy; E Moore; L Crush; S Prendeville; M M Maher; L Burke; M T Henry
Journal:  Lung       Date:  2014-11-09       Impact factor: 2.584

Review 3.  High-resolution CT of complications of idiopathic fibrotic lung disease.

Authors:  C R Lloyd; S L F Walsh; D M Hansell
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

4.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

Review 5.  High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis.

Authors:  N Sverzellati; M De Filippo; T Bartalena; S Piciucchi; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

6.  Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).

Authors:  Yan Cai; Lei Zhu; Fan Zhang; Gang Niu; Seulki Lee; Shioko Kimura; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2013-05-08       Impact factor: 4.939

7.  Tonsillar metastasis of small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.

Authors:  Eo Jin Kim; So Ri Kim; Su Jin Gang; Seung Yong Park; Young Min Han; Yong Chul Lee
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

8.  Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Authors:  AliReza JafariNezhad; Mohammad Hossein YektaKooshali
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

9.  Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis.

Authors:  Eisuke Kato; Noboru Takayanagi; Yotaro Takaku; Naho Kagiyama; Tetsu Kanauchi; Takashi Ishiguro; Yutaka Sugita
Journal:  ERJ Open Res       Date:  2018-02-02

10.  Prevalence, risk factors, and impact of lung Cancer on outcomes of idiopathic pulmonary fibrosis: a study from the Middle East.

Authors:  Sherif Mohamed; Hassan Bayoumi; Nashwa Abd El-Aziz; Ehab Mousa; Yasser Gamal
Journal:  Multidiscip Respir Med       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.